Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Leeuw, P. W.
Right arrow Articles by Staessen, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Leeuw, P. W.
Right arrow Articles by Staessen, J. A.
J Am Soc Nephrol 13:2213-2222, 2002
© 2002 American Society of Nephrology

Prognostic Significance of Renal Function in Elderly Patients with Isolated Systolic Hypertension: Results from the Syst-Eur Trial

Peter W. de Leeuw*, Lutgarde Thijs{dagger}, Willem H. Birkenhäger{ddagger}, Sophia M. Voyaki§, Aris D. Efstratopoulos§, Robert H. Fagard{dagger}, Gastone Leonetti, Choudomir Nachev||, James C. Petriea,#, José L. Rodicio*,*, Joseph J. Rosenfeld{dagger},{dagger}, Cinzia Sarti{ddagger},{ddagger} and Jan A. Staessen{dagger} for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

*Department of Internal Medicine, University of Maastricht, Maastricht, The Netherlands; {dagger}Studiecoördinatiecentrum, Hypertensie en Cardiovasculaire Revalidatie Eenheid, Departement Moleculair en Cardiovasculair Onderzoek, Katholieke Universiteit, Leuven, Belgium; {ddagger}Erasmus University, Rotterdam, The Netherlands; §Department of Internal Medicine and Hypertension Unit, General Hospital of Athens, Athens, Greece; Istituto Auxologico Italiano and the Centro di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, Universitá di Milano, Milan, Italy; ||Department of Internal Medicine, Alexandrov’s University Hospital, Sofia, Bulgaria; #Department of Medicine and Therapeutics, University of Aberdeen, Abderdeen, Scotland; **Unidad de Hypertensión, Hospital 12 de Octubre, Madrid, Spain; {dagger}{dagger}Sackler School of Medicine, Tel Aviv, Israel; and {ddagger}{ddagger}National Public Health Institute, Helsinki, Finland.

Correspondence to Dr. Peter W. de Leeuw, Department of Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Phone: 31-43-387-7005; Fax: 31-43-387-5006; E-mail: p.deleeuw{at}intmed.unimaas.nl

ABSTRACT. Several reports suggest that markers of renal function such as serum creatinine, serum uric acid, and urinary excretion of protein may be related to cardiovascular complications and mortality. This study analyzed the data from the Syst-Eur trial, which was a randomized, placebo-controlled, double-blind intervention trial in elderly patients with isolated systolic hypertension. The purpose was to evaluate whether serum levels of creatinine and uric acid and urinary protein excretion at entry are related to subsequent morbidity and mortality. Incidence rates of total mortality, cardiovascular mortality, stroke (fatal as well as nonfatal), coronary events, and all cardiovascular endpoints were calculated for each quintile of serum creatinine or serum uric acid or for each category of protein excretion (none, trace, and overt). Crude and adjusted relative hazard rates were also determined for each 20 µM increase in serum creatinine, each 50 µM increase in serum uric acid, and for each protein excretion category. Even when adjusted for age, gender, and various other covariates, serum creatinine was significantly associated with a worse prognosis. There was an U-shaped relationship between serum uric acid and total mortality, but otherwise no obvious relationships were detected between serum uric acid levels and complications when appropriate adjustments were made for confounding variables. Proteinuria at entry was a significant predictor of total mortality and all cardiovascular endpoints. It is concluded that higher levels of serum creatinine and trace or overt proteinuria are associated with an increased number of cardiovascular events and with a higher mortality in patients with isolated systolic hypertension.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Covic, A. Schiller, N.-G. Mardare, L. Petrica, M. Petrica, A. Mihaescu, and N. Posta
The impact of acute kidney injury on short-term survival in an Eastern European population with stroke
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2228 - 2234.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. Ovbiagele
Impairment in Glomerular Filtration Rate or Glomerular Filtration Barrier and Occurrence of Stroke
Arch Neurol, July 1, 2008; 65(7): 934 - 938.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Farbom, B. Wahlstrand, P. Almgren, S. Skrtic, J. Lanke, L. Weiss, S. Kjeldsen, T. Hedner, and O. Melander
Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension: The Nordic Diltiazem Study
Hypertension, July 1, 2008; 52(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. P. Obermayr, C. Temml, M. Knechtelsdorfer, G. Gutjahr, J. Kletzmayr, S. Heiss, A. Ponholzer, S. Madersbacher, R. Oberbauer, and R. Klauser-Braun
Predictors of new-onset decline in kidney function in a general middle-european population
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1265 - 1273.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. Nogueira and M. Weir
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 766 - 785.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al.
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur. Heart J., June 11, 2007; (2007) ehm236v1.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. M.H. Hermans, R. Henry, J. M. Dekker, J. P. Kooman, P. J. Kostense, G. Nijpels, R. J. Heine, and C. D.A. Stehouwer
Estimated Glomerular Filtration Rate and Urinary Albumin Excretion Are Independently Associated with Greater Arterial Stiffness: The Hoorn Study
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1942 - 1952.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Schillaci, M. Pirro, M. R. Mannarino, G. Pucci, G. Savarese, S. S. Franklin, and E. Mannarino
Relation Between Renal Function Within the Normal Range and Central and Peripheral Arterial Stiffness in Hypertension
Hypertension, October 1, 2006; 48(4): 616 - 621.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Koren-Morag, U. Goldbourt, and D. Tanne
Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease.
Neurology, July 25, 2006; 67(2): 224 - 228.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. Douglas, P. G. O'Malley, and J. L. Jackson
Meta-Analysis: The Effect of Statins on Albuminuria
Ann Intern Med, July 18, 2006; 145(2): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A. X. Garg
Chronic Kidney Disease and Mortality Risk: A Systematic Review
J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2034 - 2047.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. H. Jee, L. E. Boulware, E. Guallar, I. Suh, L. J. Appel, and E. R. Miller III
Direct, Progressive Association of Cardiovascular Risk Factors With Incident Proteinuria: Results From the Korea Medical Insurance Corporation (KMIC) Study
Arch Intern Med, October 24, 2005; 165(19): 2299 - 2304.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox)
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. J. Sarnak, R. Katz, C. O. Stehman-Breen, L. F. Fried, N. S. Jenny, B. M. Psaty, A. B. Newman, D. Siscovick, M. G. Shlipak, and and the Cardiovascular Health Study*
Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
Ann Intern Med, April 5, 2005; 142(7): 497 - 505.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. C. Verhave, P. Fesler, G. du Cailar, J. Ribstein, M. E. Safar, and A. Mimran
Elevated Pulse Pressure Is Associated With Low Renal Function in Elderly Patients With Isolated Systolic Hypertension
Hypertension, April 1, 2005; 45(4): 586 - 591.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. W. de Leeuw, L. M. Ruilope, C. R. Palmer, M. J. Brown, A. Castaigne, G. Mancia, T. Rosenthal, and G. Wagener
Clinical Significance of Renal Function in Hypertensive Patients at High Risk: Results From the INSIGHT Trial
Arch Intern Med, December 13, 2004; 164(22): 2459 - 2464.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Orlowski
Update in Nephrology
Ann Intern Med, January 20, 2004; 140(2): 106 - 111.
[Full Text] [PDF]


Home page
HypertensionHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Hypertension, November 1, 2003; 42(5): 1050 - 1065.
[Full Text] [PDF]


Home page
CirculationHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Circulation, October 28, 2003; 108(17): 2154 - 2169.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A.M. Sharma
Renal involvement in hypertensive cardiovascular disease
Eur. Heart J. Suppl., August 1, 2003; 5(suppl_F): F12 - F18.
[Abstract] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. Denson
Commentary: Help! Grandma's Stroking: Balancing Morbidity and Mortality in the Treatment of Hypertension Among the Very Old
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2003; 58(7): M660 - 661.
[Full Text] [PDF]


Home page
HypertensionHome page
R. J. Johnson, D.-H. Kang, D. Feig, S. Kivlighn, J. Kanellis, S. Watanabe, K. R. Tuttle, B. Rodriguez-Iturbe, J. Herrera-Acosta, and M. Mazzali
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Hypertension, June 1, 2003; 41(6): 1183 - 1190.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. N. Reddan and P. S. Klassen
Chronic Kidney Disease and Cardiovascular Risk: Time to Focus on Therapy
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2415 - 2416.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP